Investment Committee

Overview

Investment Team Leadership

Jason Breaux, Chairman & Director

Kathy Briscoe , Chairwoman of the Nominating & Corporate Governance Committee & Director*

Susan Lee , Chairwoman of the Audit Committee & Director

Martha Solis-Turner , Director

Christopher Wright , Director

Get started

Individual Investors

Talk to your financial advisor to learn more about the Crescent Private Credit Income Corp.

Financial Advisors

Contact Advisors Asset Management for more information about how to invest in the Crescent Private Credit Income Corp.

Contact Us

(888) 875-0116
Alternatives@aamlive.com

Check the background of this firm on FINRA's Broker Check

All data as of June 30, 2024, unless otherwise noted.

The Net Asset Value ("NAV") per share for each class of shares is determined by dividing the value of total assets (including accrued interest, dividends and assets purchased with borrowings) attributable to the class minus liabilities (including accrued expenses, any reserves established by the Adviser in its discretion for contingent liabilities and any borrowings) attributable to the class by the total number of Common Shares outstanding of the class at the date as of which the determination is made.
As of June 30, 2023. Annualized Distribution Rate reflects the current month’s distribution annualized and divided by the prior month’s last reported NAV. Past performance is not necessarily indicative of future results. There is no assurance we will pay distributions. Distributions may be funded from sources other than cash flow from operations, including, without limitation, the sale of assets, borrowings, return of capital or offering proceeds. Distributions paid from offering proceeds may constitute a return of capital. We have no limits on the amounts we may pay from such sources to fund distributions. Distributions may also be funded in significant part, directly or indirectly from temporary waivers or expense reimbursements borne by the Adviser or its affiliates that may be subject to reimbursement to the Adviser or its affiliates, and therefore can reduce future distributions to which you would otherwise be entitled. The extent to which we pay distributions from sources other than cash flow from operations will depend on various factors, including the level of participation in our distribution reinvestment plan, how quickly we invest the proceeds from this offering (and any future offering) and the performance of our investments. Funding distributions from the sales of assets, borrowings, return of capital or proceeds of this offering will result in us having less funds available to acquire investments. As a result, the return you realize on your investment may be reduced. Doing so may also negatively impact our ability to generate cash flows. Likewise, funding distributions from the sale of additional securities will dilute your interest on a percentage basis and may impact the value of your investment especially if we sell these securities at prices less than the price you paid for your shares. We believe the likelihood that we pay distributions from sources other than cash flow from operations will be higher in the early stages of the offering.
As of June 30, 2024. Crescent Capital Group LP (“Crescent”) is a global credit investment manager with over $42 billion of assets under management. For over 30 years, the firm has focused on below investment grade credit through strategies that invest in marketable and privately originated debt securities including senior bank loans, high yield bonds, as well as private senior, unitranche and junior debt securities. Crescent is headquartered in Los Angeles with offices in New York, Boston, Chicago and London with more than 225 employees globally. Crescent is a part of SLC Management, the institutional alternatives and traditional asset management business of Sun Life. Crescent is an affiliate of Crescent Cap NT Advisors, LLC, Crescent Private Credit Income Corp.’s investment adviser (the “Adviser” and, collectively with its affiliates, “Crescent”).

Assets Under Management (“AUM”) refers to the assets that we manage and are generally equal to the sum of (i) net asset value (“NAV”); (ii) drawn and undrawn debt; and (iii) uncalled capital commitments.

DISCLOSURES

Before investing, consider the CPCI's investment objectives, risks, charges and expenses. Please read the prospectus carefully before investing.

The words “we,” “us,” “our” and the “Fund” refer to CPCI.

This sales and advertising literature is neither an offer to sell nor a solicitation of an offer to buy any. An offering is made only by the Fund's prospectus. This literature must be read in conjunction with the Fund's prospectus in order to fully understand all of the implications and risks of the offering of securities to which the Fund's prospectus relates. A copy of the Fund's prospectus must be made available to you in connection with any offering. Neither the Securities and Exchange Commission, nor any other state securities regulator has approved or disapproved of our common shares, determined if the Fund's prospectus is truthful or complete, or passed on or endorsed the merits of the offering. Any representation to the contrary is a criminal offense.

Risk Factors

An investment in common shares (the “shares”) of beneficial interest in CPCI involves a high degree of risk. You should only purchase shares of CPCI if you can afford to lose your complete investment. Prior to making an investment, you should read the Fund's prospectus, including the “Risk Factors” section therein, which contains a discussion of the risks and uncertainties that CPCI believes are material to its business, operating results, prospects and financial condition. These risks include, but are not limited to, the following:

CPCI has no prior operating history and there is no assurance that it will achieve its investment objective.
You should not expect to be able to sell your shares regardless of how well CPCI performs.
You should consider that you may not have access to the money you invest for an extended period of time.
CPCI does not intend to list the shares on any securities exchange, and it does not expect a secondary market in the shares to develop prior to any listing.
Because you may be unable to sell your shares, you will be unable to reduce your exposure in any market downturn.
CPCI has implemented a share repurchase program, but only a limited number of shares will be eligible for repurchase, and repurchases will be subject to available liquidity and other significant restrictions.
An investment in the shares is not suitable for you if you need access to the money you invest. See “Suitability Standards” and “Share Repurchase Program” in the Fund's prospectus.
CPCI cannot guarantee that it will make distributions, and if it does, it may fund such distributions from sources other than cash flow from operations, including, without limitation, the sale of assets, borrowings, return of capital or offering proceeds, and there are no limits on the amounts CPCI may pay from such sources.
Distributions may also be funded in significant part, directly or indirectly, from temporary waivers or expense reimbursements borne by Crescent Cap NT Advisors, LLC (the “Adviser”) or its affiliates and which may be subject to reimbursement to the Adviser or its affiliates. The repayment of any amounts owed to CPCI’s affiliates will reduce future distributions to which you would otherwise be entitled.
CPCI expects to use leverage, which will magnify the potential loss on amounts invested in it.
CPCI qualifies as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act, which means that it is eligible to take advantage of certain exemptions from various reporting and disclosure requirements that are applicable to public companies that are not emerging growth companies, and CPCI cannot be certain whether or not the reduced disclosure requirements applicable to emerging growth companies will make its shares less attractive to investors.
CPCI intends to invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below-investment-grade securities, which are often referred to as “junk,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal. They may also be illiquid and difficult to value.

Forward-Looking Statements

The sales and advertising literature presented on this website contains forward-looking statements about CPCI’s business, including, in particular, statements about its plans, strategies and objectives. You can generally identify forward-looking statements by the use of forward-looking terminology such as “may,” “will,” “expect,” “intend,” “anticipate,” “estimate,” “believe,” “continue” or other similar words. These statements include CPCI’s financial projections and estimates and their underlying assumptions, plans and objectives for future operations, including plans and objectives relating to future growth and availability of funds, and they are based on current expectations that involve numerous risks and uncertainties. Assumptions relating to these statements involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to accurately predict and most of which are beyond CPCI’s control. Although CPCI believes the assumptions underlying the forward-looking statements, and the forward-looking statements themselves, are reasonable, any of the assumptions could be inaccurate and, therefore, there is no assurance that these forward-looking statements will prove to be accurate, and CPCI’s actual results, performance and achievements may be materially different from that expressed or implied by these forward-looking statements. In light of the significant uncertainties inherent in these forward-looking statements, the inclusion of this information should not be regarded as a representation by CPCI or any person that the CPCI’s objectives and plans, which it considers to be reasonable, will be achieved.

You should carefully review the “Risk Factors” section of the Fund's prospectus, and any updated factors included in CPCI’s periodic filings with the Securities and Exchange Commission (the "SEC"), which will be accessible on the SEC's website at www.sec.gov, for a discussion of the risks and uncertainties that CPCI believes are material to its business, operating results, prospects and financial condition. These factors should not be construed as exhaustive, and they should be read in conjunction with the other cautionary statements that are included in this document (or the Fund's prospectus and other SEC filings). Except as otherwise required by federal securities laws, CPCI does not undertake to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Privacy Policy
Terms of Use
Cookies Policy

Powered By Q4 Inc. 5.133.2.5 (opens in new window)

Important Notice

This site and the materials herein are directed only to certain types of investors and to persons in jurisdictions where Crescent Private Credit Income Corp. (CPCI) is authorized for distribution.

Complete information about investing in shares of CPCI is available in the prospectus. An investment in CPCI involves risks.

Download Prospectus

I acknowledge that (i) I have received the Prospectus and (ii) either (a) I am a United States resident or (b) I have otherwise received authorization from my broker-dealer/registered investment advisor to access the contents of this website.

State of Residence

By selecting a state from the above list, you certify that you are resident in that state.

Leave Site